Pomegranate juice may inhibit the spread of prostate cancer

Studies have found certain components in pomegranate juice to weaken and prevent the movement of cancer cells, specifically prostate cancer. Researchers from the University of California, Riverside have been testing this and similar theories.

As one of the leading causes of death in men in the United States, prostate cancer affects millions of individuals. The causes are unknown, and there is no cure at this time. Initial treatments of prostate cancer include testosterone suppression therapy which is typically a short-term solution. Eventually, the disease spreads to the lungs, bone marrow, and lymph nodes. If the disease spreads, it is typically deadly.

As researchers added pomegranate juice to cancer cells in a laboratory setting, it was discovered that the juice caused a decrease in cancer cell migration.

The most important ingredients in pomegranate juice impacting cell migration are: phenylpropanoids, conjugated fatty acids, flavones, and hydrobenzoic acid.

This discovery allows experts to formulate modifications of pomegranate juice to assist in further decreases of cancer migration and/or prevention.

Researchers also noticed pomegranate juice to potentially prevent the spread of prostate cancer cells to bone marrow.

Additional studies will be performed with the intention of determining the potency of juice required and what side effects exist.